Prenetics Global (PRE) Revenue & Revenue Breakdown
Prenetics Global Revenue Highlights
Latest Revenue (Y)
$21.74M
Latest Revenue (Q)
$6.41M
Main Geography (Y)
HONG KONG
Prenetics Global Revenue by Period
Prenetics Global Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $21.74M | -92.12% |
| 2022-12-31 | $275.76M | -0.03% |
| 2021-12-31 | $275.85M | 323.22% |
| 2020-12-31 | $65.18M | 605.93% |
| 2019-12-31 | $9.23M | - |
Prenetics Global generated $21.74M in revenue during NA 2023, up -92.12% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Prenetics Global Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $6.41M | 18.14% |
| 2023-12-31 | $5.43M | 11.57% |
| 2023-09-30 | $4.87M | -14.57% |
| 2023-06-30 | $5.70M | -67.82% |
| 2023-03-31 | $17.70M | -66.17% |
| 2022-12-31 | $52.32M | -34.34% |
| 2022-09-30 | $79.68M | 54.07% |
| 2022-06-30 | $51.72M | -43.81% |
| 2022-03-31 | $92.04M | 42.23% |
| 2021-12-31 | $64.72M | -13.32% |
| 2021-09-30 | $74.66M | -5.52% |
| 2021-06-30 | $79.02M | 37.54% |
| 2021-03-31 | $57.45M | - |
Prenetics Global generated $6.41M in revenue during Q1 2024, up 18.14% compared to the previous quarter, and up 12.26% compared to the same period a year ago.
Prenetics Global Revenue Breakdown
Prenetics Global Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 |
|---|---|---|
| HONG KONG | $12.92M | $210.93M |
| Rest Of The World | $1.18M | - |
| TAIWAN | $9.33M | - |
Prenetics Global's latest annual revenue breakdown by geography, as of Dec 23: HONG KONG (55.14%), TAIWAN (39.81%), and Rest Of The World (5.06%).
Prenetics Global Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| QGEN | Qiagen | $1.97B | $458.80M |
| NEOG | Neogen | $924.22M | $228.81M |
| GTH | Genetron | $650.71M | $201.32M |
| NOTV | Inotiv | $572.42M | $105.79M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| LMDX | LumiraDx | $254.48M | $21.00M |
| CSTL | Castle Biosciences | $219.79M | $87.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| FONR | FONAR | $98.65M | $25.72M |
| MDXH | MDxHealth SA | $70.19M | $19.83M |
| XGN | Exagen | $52.55M | $15.06M |
| BDSX | Biodesix | $49.09M | $14.82M |
| ACRS | Aclaris Therapeutics | $31.25M | $2.40M |
| PRE | Prenetics Global | $21.74M | $6.41M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| SERA | Sera Prognostics | $306.00K | - |
PRE Revenue FAQ
What is Prenetics Global’s yearly revenue?
Prenetics Global's yearly revenue for 2023 was $21.74M, representing a decrease of -92.12% compared to 2022. The company's yearly revenue for 2022 was $275.76M, representing a decrease of -0.03% compared to 2021. PRE's yearly revenue for 2021 was $275.85M, representing an increase of 323.22% compared to 2020.
What is Prenetics Global’s quarterly revenue?
Prenetics Global's quarterly revenue for Q1 2024 was $6.41M, a 18.14% increase from the previous quarter (Q4 2023), and a -63.77% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $5.43M, a 11.57% increase from the previous quarter (Q3 2023), and a -89.62% decrease year-over-year (Q4 2022). PRE's quarterly revenue for Q3 2023 was $4.87M, a -14.57% decrease from the previous quarter (Q2 2023), and a -93.89% decrease year-over-year (Q3 2022).
What is Prenetics Global’s revenue growth rate?
Prenetics Global's revenue growth rate for the last 3 years (2021-2023) was -92.12%, and for the last 5 years (2019-2023) was 135.49%.